Sprott Inc. Sells 5,000 Shares of Lam Research Co. (NASDAQ:LRCX)

Sprott Inc. trimmed its position in shares of Lam Research Co. (NASDAQ:LRCX) by 9.1% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 50,000 shares of the semiconductor company’s stock after selling 5,000 shares during the quarter. Lam Research makes up approximately 2.2% of Sprott Inc.’s holdings, making the stock its 16th largest position. Sprott Inc.’s holdings in Lam Research were worth $9,392,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of LRCX. FMR LLC boosted its position in Lam Research by 13.7% during the 1st quarter. FMR LLC now owns 7,565,824 shares of the semiconductor company’s stock valued at $1,354,358,000 after acquiring an additional 913,293 shares in the last quarter. Amundi Pioneer Asset Management Inc. boosted its position in Lam Research by 563.0% during the 1st quarter. Amundi Pioneer Asset Management Inc. now owns 1,043,217 shares of the semiconductor company’s stock valued at $186,745,000 after acquiring an additional 885,862 shares in the last quarter. Lansdowne Partners UK LLP bought a new stake in Lam Research during the 2nd quarter valued at approximately $148,977,000. Marshall Wace North America L.P. boosted its position in Lam Research by 249.2% during the 1st quarter. Marshall Wace North America L.P. now owns 582,106 shares of the semiconductor company’s stock valued at $104,202,000 after acquiring an additional 415,418 shares in the last quarter. Finally, Geode Capital Management LLC boosted its position in Lam Research by 18.6% during the 4th quarter. Geode Capital Management LLC now owns 2,519,701 shares of the semiconductor company’s stock valued at $342,720,000 after acquiring an additional 395,218 shares in the last quarter. 88.43% of the stock is currently owned by institutional investors and hedge funds.

In related news, Director Abhijit Y. Talwalkar sold 3,987 shares of the business’s stock in a transaction that occurred on Wednesday, July 24th. The shares were sold at an average price of $210.00, for a total value of $837,270.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Sarah A. O’dowd sold 22,140 shares of the business’s stock in a transaction that occurred on Wednesday, September 11th. The stock was sold at an average price of $233.77, for a total transaction of $5,175,667.80. The disclosure for this sale can be found here. Insiders have sold 67,997 shares of company stock valued at $14,854,855 over the last quarter. Company insiders own 0.44% of the company’s stock.



Several analysts have weighed in on LRCX shares. Needham & Company LLC lifted their price objective on Lam Research from $220.00 to $250.00 and gave the company a “buy” rating in a research report on Friday. BidaskClub raised Lam Research from a “buy” rating to a “strong-buy” rating in a research report on Saturday. Wells Fargo & Co lifted their price objective on Lam Research from $195.00 to $200.00 and gave the company a “market perform” rating in a research report on Thursday, August 1st. KeyCorp lifted their price objective on Lam Research from $236.00 to $252.00 and gave the company an “overweight” rating in a research report on Thursday, August 1st. Finally, DA Davidson cut Lam Research from a “buy” rating to a “neutral” rating and cut their price objective for the company from $225.00 to $200.00 in a research report on Monday, July 8th. Eleven equities research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $221.88.

Shares of LRCX stock traded down $0.36 during trading hours on Monday, hitting $235.20. 490,626 shares of the company’s stock traded hands, compared to its average volume of 1,535,410. The stock’s fifty day simple moving average is $209.00 and its two-hundred day simple moving average is $192.53. Lam Research Co. has a 12-month low of $122.64 and a 12-month high of $237.90. The stock has a market cap of $33.86 billion, a price-to-earnings ratio of 16.16, a PEG ratio of 1.44 and a beta of 1.62. The company has a quick ratio of 2.96, a current ratio of 3.61 and a debt-to-equity ratio of 0.81.

Lam Research (NASDAQ:LRCX) last released its earnings results on Wednesday, July 31st. The semiconductor company reported $3.62 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $3.40 by $0.22. Lam Research had a net margin of 22.70% and a return on equity of 43.72%. The firm had revenue of $2.36 billion during the quarter, compared to analyst estimates of $2.37 billion. During the same period last year, the business earned $5.31 earnings per share. The business’s revenue was down 24.5% on a year-over-year basis. On average, equities analysts forecast that Lam Research Co. will post 13.6 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 16th. Stockholders of record on Tuesday, October 1st will be issued a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a dividend yield of 1.96%. This is a positive change from Lam Research’s previous quarterly dividend of $1.10. The ex-dividend date of this dividend is Monday, September 30th. Lam Research’s dividend payout ratio (DPR) is presently 30.24%.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits worldwide. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition product for copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatment; SPEED gapfill high-density plasma chemical vapor deposition (CVD) products; Striker single-wafer atomic layer deposition (ALD) products; and VECTOR plasma-enhanced CVD ALD products.

Recommended Story: Why is a lock-up period needed for an IPO?

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Co. (NASDAQ:LRCX).

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.